Ads
related to: Treatment Macular Degenerationeylea.us has been visited by 10K+ users in the past month
Iveric bio, Still A 5+% Opportunity (NASDAQ:ISEE)
Seeking Alpha· 21 hours ago(OTCPK:ALPMF). The company's valuation is driven by its lead drug Avacincaptad pegol, which is an investigational drug for the treatment of geographic...
Apellis' (APLS) Study on Pegcetacoplan to Treat ALS Fails
Zacks via Yahoo Finance· 5 days agoApellis' (APLS) phase II MERIDIAN study on pegcetacoplan for thetreatment of amyotrophic lateral...
Kodiak (KOD) Advances With Tarcocimab Amid Stiff Competition
Zacks· 1 day agoKodiak (KOD) focuses on completing ongoing studies on tarcocimab for several retinal indications. However, competition in the market and the lack of other candidates in the pipeline are concerns.
Annexon (ANNX) Stock Down More Than 50% Last Week: Here's Why
Zacks via Yahoo Finance· 1 day agoIn the monthly treatment group, the reduction in lesion growth was 6.2%, while that in the...
Alimera (ALIM) Completes Enrollment in Eye Disease Study
Zacks via Yahoo Finance· 6 days agoAlimera (ALIM) announces completion of patient enrollment in its NEW DAY study to evaluate Iluvien...
Kodiak Sciences to Present at Upcoming Investor Conferences
19 Action News Cleveland· 20 hours agoPALO ALTO, Calif., May 30, 2023 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics ...
Adverum Biotechnologies Announces New Executive Leadership Roles - Adverum Biotechnologies...
Benzinga· 6 days agoAdverum Biotechnologies, Inc. ADVM, a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced new executive ...
Molecular Partners AG (NASDAQ:MOLN) Short Interest Down 42.7% in May
ETF DAILY NEWS· 5 days agoMolecular Partners AG (NASDAQ:MOLN – Get Rating) was the recipient of a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 5,100 shares, ...
In The Know: Clemson Eye opens in Seneca; TD SYNNEX leaders recognized; Amp’d Up Fridays
Greenville News via Yahoo News· 5 days agoClemson Eye performs surgery for cataracts, glaucoma, diabetic eye disease, corneal disease, macular...
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Ocuphire...
Benzinga· 7 days agoFARMINGTON HILLS, Mich., May 24, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (NASDAQ:OCUP), today announced that the Compensation Committee of its Board of Directors, which is composed entirely of independent
Ads
related to: Treatment Macular Degeneration
